# Rowena Punzalan, M.D. – FDA Inspection, Feb 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/rowena-punzalan-md/962b5cf4-0627-402e-bc0f-8002e82b2e12
Source feed: FDA_Inspections

> FDA inspection 1260284 of Rowena Punzalan, M.D., February 07, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260284
- Company Name: Rowena Punzalan, M.D.
- Inspection Date: 2025-02-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1134798 - 2021-01-15](https://www.keypedia.com/records/fda_inspections/rowena-punzalan-md/90dc114a-d7ae-419a-b284-f4fa01ba8659)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/dina-a-tallman/e9bf2b98-6697-4d7c-9052-84339536acfd)
- [Issuing Officer](https://www.keypedia.com/people/mildred-j-tures/c21df23d-580f-4cdc-94a1-194d981e41be)

Company: https://www.keypedia.com/companies/rowena-punzalan-md/44554c9c-3025-4ef1-a531-63032a5013a3

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
